Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression.
Saved in:
| Title: | Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression. |
|---|---|
| Authors: | He Z; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Department of Urology, The Second People's Hospital of Foshan, Foshan, Guangdong, China., Gong C; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Gu J; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China., Wang W; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Li H; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Tan Z; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Wang H; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Wang J; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Ding M; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. dingmingxia@kmmu.edu.cn.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. dingmingxia@kmmu.edu.cn., Huang Y; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. huangyinglong@kmmu.edu.cn.; Urological Disease Clinical Medical Center of Yunnan Province, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. huangyinglong@kmmu.edu.cn. |
| Source: | European journal of medical research [Eur J Med Res] 2025 Aug 13; Vol. 30 (1), pp. 740. Date of Electronic Publication: 2025 Aug 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2047-783X |
|---|---|
| DOI: | 10.1186/s40001-025-03033-0 |
